BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 12429979)

  • 1. Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin (review).
    Rose DP; Gilhooly EM; Nixon DW
    Int J Oncol; 2002 Dec; 21(6):1285-92. PubMed ID: 12429979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin signaling in breast cancer: an overview.
    Cirillo D; Rachiglio AM; la Montagna R; Giordano A; Normanno N
    J Cell Biochem; 2008 Nov; 105(4):956-64. PubMed ID: 18821585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is leptin a mediator of adverse prognostic effects of obesity in breast cancer?
    Goodwin PJ; Ennis M; Fantus IG; Pritchard KI; Trudeau ME; Koo J; Hood N
    J Clin Oncol; 2005 Sep; 23(25):6037-42. PubMed ID: 16135472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity, adipocytokines, and insulin resistance in breast cancer.
    Rose DP; Komninou D; Stephenson GD
    Obes Rev; 2004 Aug; 5(3):153-65. PubMed ID: 15245384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of obesity on breast cancer development.
    Cleary MP; Grossmann ME; Ray A
    Vet Pathol; 2010 Mar; 47(2):202-13. PubMed ID: 20124008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin as a potential therapeutic target for breast cancer prevention and treatment.
    Ray A; Cleary MP
    Expert Opin Ther Targets; 2010 Apr; 14(4):443-51. PubMed ID: 20230196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression.
    Vona-Davis L; Rose DP
    Endocr Relat Cancer; 2007 Jun; 14(2):189-206. PubMed ID: 17639037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity hormone leptin: a new target in breast cancer?
    Surmacz E
    Breast Cancer Res; 2007; 9(1):301. PubMed ID: 17274833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and breast cancer: status of leptin and adiponectin in pathological processes.
    Grossmann ME; Ray A; Nkhata KJ; Malakhov DA; Rogozina OP; Dogan S; Cleary MP
    Cancer Metastasis Rev; 2010 Dec; 29(4):641-53. PubMed ID: 20821253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Energy balance adiposity and breast cancer - energy restriction strategies for breast cancer prevention.
    Harvie M; Howell A
    Obes Rev; 2006 Feb; 7(1):33-47. PubMed ID: 16436101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer and obesity: an update.
    Stephenson GD; Rose DP
    Nutr Cancer; 2003; 45(1):1-16. PubMed ID: 12791499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcellular localization of cyclic AMP-responsive element binding protein-regulated transcription coactivator 2 provides a link between obesity and breast cancer in postmenopausal women.
    Brown KA; McInnes KJ; Hunger NI; Oakhill JS; Steinberg GR; Simpson ER
    Cancer Res; 2009 Jul; 69(13):5392-9. PubMed ID: 19509226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-1 family in breast cancer: potential interplay with leptin and other adipocytokines.
    Perrier S; Caldefie-Chézet F; Vasson MP
    FEBS Lett; 2009 Jan; 583(2):259-65. PubMed ID: 19111549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer.
    Vona-Davis L; Howard-McNatt M; Rose DP
    Obes Rev; 2007 Sep; 8(5):395-408. PubMed ID: 17716297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NFkappaB pathway and endocrine-resistant breast cancer.
    Zhou Y; Eppenberger-Castori S; Eppenberger U; Benz CC
    Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S37-46. PubMed ID: 16113098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer.
    Yamaguchi Y; Takei H; Suemasu K; Kobayashi Y; Kurosumi M; Harada N; Hayashi S
    Cancer Res; 2005 Jun; 65(11):4653-62. PubMed ID: 15930283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular links between obesity and breast cancer.
    Lorincz AM; Sukumar S
    Endocr Relat Cancer; 2006 Jun; 13(2):279-92. PubMed ID: 16728564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity and breast cancer: progress to understanding the relationship.
    Brown KA; Simpson ER
    Cancer Res; 2010 Jan; 70(1):4-7. PubMed ID: 20028864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory talk: linking obesity, NF-κB, and Aromatase.
    Hursting SD
    Cancer Prev Res (Phila); 2011 Mar; 4(3):285-7. PubMed ID: 21372024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.